Stem cell therapy for spinal cord injury

Current Medicinal Chemistry

Volumn 17, Issue 36, 2010, Pages 4492-4510

  Kan, E M ^a   Ling, E A ^b   Lu, J ^a  

^a Defence Medical and Environmental Research Institute   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Adult stem cells; Embryonic stem cells; Induced pluripotent stem cells; Spinal cord injury; Stem cell therapy

Indexed keywords

4 AMINOPYRIDINE; AMINOPYRIDINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CHONDROITIN ABC LYASE; CILIARY NEUROTROPHIC FACTOR; GACYCLIDINE; KRUPPEL LIKE FACTOR 4; LAZAROID; MATRIX METALLOPROTEINASE; METHYLPREDNISOLONE; MONOSIALOGANGLIOSIDE; MYC PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELIN; NALOXONE; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NIMODIPINE; OCTAMER TRANSCRIPTION FACTOR 4; PLACEBO; PROTEINASE INHIBITOR; SILDENAFIL; SOMATOMEDIN; TADALAFIL; TEMPOL; TIRILAZAD; TIZANIDINE; TRANSCRIPTION FACTOR SOX2; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADULT STEM CELL; ALLODYNIA; AMNION CELL; ARTICLE; ASTROCYTOSIS; BLASTOCYST; BONE MARROW CELL; CARCINOGENESIS; CARCINOGENICITY; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; EDEMA; EMBRYONIC STEM CELL; GENE OVEREXPRESSION; GLIA; GOVERNMENT REGULATION; GRAFT REJECTION; HAIR FOLLICLE; HUMAN; INFLAMMATION; MEDICAL ETHICS; MOTOR COORDINATION; NERVE CELL PLASTICITY; NERVE GRAFT; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; OLFACTORY ENSHEATHING CELL; OLIGODENDROGLIA; PATIENT SAFETY; PLURIPOTENT STEM CELL; REMYELINIZATION; SCAR; SPINAL CORD COMPRESSION; SPINAL CORD DECOMPRESSION; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA; SPINE STABILIZATION; STEM CELL TRANSPLANTATION; SYNAPTIC TRANSMISSION; TERATOMA; UMBILICAL CORD BLOOD;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION;

EID: 78650647708     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710794182971     Document Type: Article

References (228)

1. Sekhon, L. H.; Fehlings, M. G. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine, 2001, 26 (24 Suppl), S2-12.
2. National Spinal Cord Injury Statistical Center. Spinal cord injury. Facts and figures at a glance. J. Spinal Cord Med., 2005, 28(4), 379-380.
3. Orlacchio, A.; Bernardi, G.; Martino, S. Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases. Curr. Med. Chem., 2010, 17(7), 595-608.
4. Bareyre, F. M.; Kerschensteiner, M.; Raineteau, O.; Mettenleiter, T. C.; Weinmann, O.; Schwab, M. E. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat. Neurosci., 2004, 7(3), 269-277.
5. Sedy, J.; Zicha, J.; Kunes, J.; Jendelová, P.; Syková, E. Rapid but not slow spinal cord compression elicits neurogenic pulmonary edema in the rat. Physiol. Res., 2009, 58(2), 269-277.
6. Swartz, K. R.; Scheff, N. N.; Roberts, K. N.; Fee, D. B. Exacerbation of spinal cord injury due to static compression occurring early after onset. J. Neurosurg., 2009, 11(5), 570-574.
7. Fehlings, M. G. The impact of continued cord compression following traumatic spinal cord injury. J. Neurosurg., 2009, 11(5), 568-569.
8. McDonald, J. W.; Belegu, V. Demyelination and remyelination after spinal cord injury. J. Neurotrauma, 2006, 23 (3-4), 345-359.
9. Grigoriadis, N.; Ben-Hur, T; Karussis, D.; Milonas, I. Axonal damage in multiple sclerosis: a complex issue in a complex disease. Clin. Neurol. Neurosurg., 2004, 106(3), 211-217.
10. Menet, V.; Prieto, M.; Privat, A.; Giménez y Ribotta, M. Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc. Natl. Acad. Sci. U. S A., 2003, 100(15), 8999-9004.
11. Faulkner, J. R.; Herrmann, J. E.; Woo, M. J.; Tansey, K. E.; Doan, N. B.; Sofroniew, M. V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci., 2004, 24(9), 2143-2155.
12. Okada, S.; Nakamura, M.; Katoh, H.; Miyao, T; Shimazaki, T; Ishii, K.; Yamane, J.; Yoshimura, A.; Iwamoto, Y.; Toyama, Y.; Okano, H. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med., 2006, 12(7), 829-834.
13. Busch, S. A.; Silver, J. The role of extracellular matrix in CNS regeneration. Curr. Opin. Neurobiol, 2007, 17(1), 120-127.
14. McKeon, R. J.; Schreiber, R. C.; Rudge, J. S.; Silver, J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci., 1991, 11(11), 3398-3411.
15. Bundesen, L. Q.; Scheel, T. A.; Bregman, B. S.; Kromer, L. F. Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. Journal of Neuroscience, 2003, 23(21), 7789-7800.
16. Pasterkamp, R. J.; Verhaagen, J. Emerging roles for semaphorins in neural regeneration. Brain Res. Brain Res. Rev., 2001, 35(1), 36-54.
17. Grand Pré, T.; Nakamura, F.; Vartanian, T.; Strittmatter, S. M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature, 2000, 403(6768), 439-444.
18. Chen, M. S.; Huber, A. B.; van der Haar, M. E.; Frank, M.; Schnell, L.; Spillmann, A. A.; Christ, F.; Schwab, M. E. Nogo-A is a myelinassociated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature, 2000, 403(6768), 434-439.
19. Wang, K. C.; Koprivica, V.; Kim, J. A.; Sivasankaran, R.; Guo, Y.; Neve, R. L.; He, Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature, 2002, 417(6892), 941-944.
20. Bracken, M. B.; Shepard, M. J.; Holford, T. R.; Leo-Summers, L.; Aldrich, E. F.; Fazl, M.; Fehlings, M.; Herr, D. L.; Hitchon, P. W.; Marshall, L. F.; Nockels, R. P.; Pascale, V.; Perot, P. L.; Piepmeier, J.; Sonntag, V. K.; Wagner, F.; Wilberger, J. E.; Winn, H. R.; Young, W. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA, 1997, 277(20), 1597-1604.
21. Geisler, F. H.; Coleman, W. P.; Grieco, G.; Poonian, D. The Sygen multicenter acute spinal cord injury study. Spine, 2001, 26 (24 Suppl), S87-98.
22. Ibarra, A.; Martiñón, S. Pharmacological approaches to induce neuroregeneration in spinal cord injury: an overview. Curr. Drug Disc. Technol., 2009, 6(2), 82-90.
23. Onose, G.; Anghelescu, A.; Muresanu, D. F.; Padure, L.; Haras, M. A.; Chendreanu, C. O.; Onose, L. V.; Mirea, A.; Ciurea, A. V.; El Masri, W. S.; von Wild, K. R. H. A review of published reports on neuroprotection in spinal cord injury. Spinal Cord, 2009, 47(10), 716-726.
24. Hillard, V. H.; Peng, H.; Zhang, Y.; Das, K.; Murali, R.; Etlinger, J. D.; Zeman, R. J. Tempol, a nitroxide antioxidant, improves locomotor and histological outcomes after spinal cord contusion in rats. J. Neurotrauma, 2004, 21(10), 1405-1414.
25. Scott, G. S.; Cuzzocrea, S.; Genovese, T.; Koprowski, H.; Hooper, D. C. Uric acid protects against secondary damage after spinal cord injury. Proc. Natl. Acad. Sci. U. S. A., 2005, 102(9), 3483-3488.
26. Pan, W.; Zhang, L.; Liao, J.; Csernus, B.; Kastin, A. J. Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI. J. Neuroimmunol., 2003, 134 (1-2), 111-117.
27. Jaeger, C. B.; Blight, A. R. Spinal cord compression injury in guinea pigs: structural changes of endothelium and its perivascular cell associations after blood-brain barrier breakdown and repair. Exp. Neurol., 1997, 144(2), 381-399.
28. Fehlings, M. G.; Sekhon, L. H. Acute interventions in spinal cord injury: what do we know, what should we do? Clin. Neurosurg., 2001, 48, 226-242.
29. Kwon, B. K.; Tetzlaff, W.; Grauer, J. N.; Beiner, J.; Vaccaro, A. R. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J, 2004, 4(4), 451-464.
30. Anderson, D. K.; Braughler, J. M.; Hall, E. D.; Waters, T. R.; McCall, J. M.; Means, E. D. Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury. J. Neurosurg., 1988, 69(4), 562-567.
31. Farooque, M.; Hillered, L.; Holtz, A.; Olsson, Y. Effect of 21-aminosteroid on extracellular energy-related metabolites and amino acids after compression injury of rat spinal cord. Exp. Brain Res., 1997, 113(1), 1-4.
32. Kunihara, T.; Sasaki, S.; Shiiya, N.; Ishikura, H.; Kawarada, Y.; Matsukawa, A.; Yasuda, K. Lazaroid reduces production of IL-8 and IL-1 receptor antagonist in ischemic spinal cord injury. Ann. Thorac. Surg., 2000, 69(3), 792-798.
33. Deng-Bryant, Y.; Singh, I. N.; Carrico, K. M.; Hall, E. D. Neuroprotective effects of tempol, a catalytic scavenger of peroxynitrite- derived free radicals, in a mouse traumatic brain injury model. J. Cereb. Blood Flow Metab., 2008, 28(6), 1114-1126.
34. Bilginer, B.; Onal, M. B.; Narin, F.; Ustun, H.; Kilinc, K.; Akalan, N. Antiapoptotic and neuroprotective effects of mycophenolate mofetil after acute spinal cord injury in young rats. Childs Nerv. Syst., 2009, 25(12), 1555-1561.
35. Serarslan, Y.; Yönden, Z.; Ozgiray, E.; Oktar, S.; Güven, E. O.; Sögüt, S.; Yilmaz, N.; Yurtseven, T. Protective effects of tadalafil on experimental spinal cord injury in rats. J. Clin. Neurosci., 2010, 17(3), 349-352.
36. Kiymaz, N.; Yilmaz, N.; Mumcu, C.; Anlar, O.; Ozen, S.; Kayaoglu, C. R. Protective effect of sildenafil (Viagra) in transient spinal cord ischemia. Pediatr. Neurosurg., 2008, 44(1), 22-28.
37. Winkler, T.; Sharma, H. S.; Stålberg, E.; Badgaiyan, R. D.; Gordh, T.; Westman, J. An L-type calcium channel blocker, nimodipine influences trauma induced spinal cord conduction and axonal injury in the rat. Acta Neurochir. Suppl. (Wien). 2003, 86, 425-432.
38. Nehrt, A.; Rodgers, R.; Shapiro, S.; Borgens, R.; Shi, R. The critical role of voltage-dependent calcium channel in axonal repair following mechanical trauma. Neuroscience, 2007, 146(4), 1504-1512.
39. Ross, I. B.; Tator, C. H. Further studies of nimodipine in experimental spinal cord injury in the rat. J. Neurotrauma, 1991, 8(4), 229-238.
40. Petitjean, M. E.; Pointillart, V.; Dixmerias, F.; Wiart, L.; Sztark, F.; Lassié, P.; Thicoïpé, M.; Dabadie, P. [Medical treatment of spinal cord injury in the acute stage]. Ann. Fr. Anesth. Reanim., 1998, 17(2), 114-122.
41. Hirbec, H.; Gaviria, M.; Vignon, J. Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor. CNS Drug Rev., 2001, 7(2), 172-198.
42. Feldblum, S.; Arnaud, S.; Simon, M.; Rabin, O.; D'Arbigny, P. Efficacy of a new neuroprotective agent, gacyclidine, in a model of rat spinal cord injury. J. Neurotrauma, 2000, 17(11), 1079-1093.
43. Wiksten, M.; Väänänen, A. J.; Liebkind, R.; Liesi, P. Regeneration of adult rat spinal cord is promoted by the soluble KDI domain of gamma1 laminin. J. Neurosci. Res., 2004, 78(3), 403-410.
44. Möykkynen, T.; Liebkind, R.; Sjöberg, J.; Korpi, E. R.; Liesi, P. The neuroprotective KDI domain of gamma 1-laminin is a universal and potent inhibitor of ionotropic glutamate receptors. J. Neurosci. Res., 2005, 81(6), 797-804.
45. Sun, W.; Smith, D.; Fu, Y; Cheng, J.-X.; Bryn, S.; Borgens, R.; Shi, R. Novel potassium channel blocker, 4-AP-3-MeOH, inhibits fast potassium channels and restores axonal conduction in injured guinea pig spinal cord white matter. J. Neurophysiol, 2010, 103(1), 469-478.
46. Colak, A.; Karaoglan, A.; Barut, S.; Köktürk, S.; Akyildiz, A. I.; Tayürekli, M. Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury. J. Neurosurg., 2005, 2(3), 327-334.
47. Sribnick, E. A.; Matzelle, D. D.; Banik, N. L.; Ray, S. K. Direct evidence for calpain involvement in apoptotic death of neurons in spinal cord injury in rats and neuroprotection with calpain inhibitor. Neurochem. Res., 2007, 32(12), 2210-2216.
48. Dubreuil, C. I.; Winton, M. J.; McKerracher, L. Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J. Cell Biol, 2003, 162(2), 233-243.
49. Qiu, J.; Cai, D.; Dai, H.; McAtee, M.; Hoffman, P. N.; Bregman, B. S.; Filbin, M. T. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron, 2002, 34(6), 895-903.
50. Whitaker, CM.; Beaumont, E.; Wells, M. J.; Magnuson, D. S. K.; Hetman, M.; Onifer, S. M. Rolipram attenuates acute oligodendrocyte death in the adult rat ventrolateral funiculus following contusive cervical spinal cord injury. Neurosci. Lett., 2008, 438(2), 200-204.
51. Ikegami, T; Nakamura, M.; Yamane, J.; Katoh, H.; Okada, S.; Iwanami, A.; Watanabe, K.; Ishii, K.; Kato, F.; Fujita, H.; Takahashi, T; Okano, H. J.; Toyama, Y; Okano, H. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur. J. Neurosci., 2005, 22(12), 3036-3046.
52. Sharma, H. S. Selected combination of neurotrophins potentiate neuroprotection and functional recovery following spinal cord injury in the rat. Acta Neurochir. Suppl. (Wien). 2010, 106, 295-300.
53. Sasaki, M.; Radtke, C.; Tan, A. M.; Zhao, P.; Hamada, H.; Houkin, K.; Honmou, O.; Kocsis, J. D. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J. Neurosci., 2009, 29(47), 14932-14941.
54. Falci, S.; Holtz, A.; Akesson, E.; Azizi, M.; Ertzgaard, P.; Hultling, C.; Kjaeldgaard, A.; Levi, R.; Ringden, O.; Westgren, M.; Lammertse, D.; Seiger, A. Obliteration of a posttraumatic spinal cord cyst with solid human embryonic spinal cord grafts: first clinical attempt. J. Neurotrauma, 1997, 14(11), 875-884.
55. Thompson, F. J.; Reier, P. J.; Uthman, B.; Mott, S.; Fessler, R. G.; Behrman, A.; Trimble, M.; Anderson, D. K.; Wirth, E. D. Neurophysiological assessment of the feasibility and safety of neural tissue transplantation in patients with syringomyelia. J. Neurotrauma, 2001, 18(9), 931-945.
56. Levi, A. D. O.; Dancausse, H.; Li, X.; Duncan, S.; Horkey, L.; Oliviera, M. Peripheral nerve grafts promoting central nervous system regeneration after spinal cord injury in the primate. J. Neurosurg., 2002, 96 (2 Suppl), 197-205.
57. Fukunaga, S.; Sasaki, S.; Fu, T.; Yokoyama, H.; Lee, I.; Nakagaki, I.; Hori, S.; Tateishi, H.; Maruo, S. Experimental study of neural repair of the transected spinal cord using peripheral nerve graft. J. Orthop. Sci., 2004, 9(6), 605-612.
58. Brunelli, G.; Spano, P.; Barlati, S.; Guarneri, B.; Barbon, A.; Bresciani, R.; Pizzi, M. Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle. Proc. Natl. Acad. Sci. U. S. A., 2005, 102(24), 8752-8757.
59. Brunelli, G.; Wild, K.v. Unsuspected plasticity of single neurons after connection of the corticospinal tract with peripheral nerves in spinal cord lesions. J. Reconstr. Microsurg., 2008, 24(4), 301-304.
60. von Wild, K. R. H.; Brunelli, G. A. Restoration of locomotion in paraplegics with aid of autologous bypass grafts for direct neurotisation of muscles by upper motor neurons-the future: surgery of the spinal cord? Acta Neurochir. Suppl. (Wien). 2003, 87, 107-112.
61. Houle, J. D.; Tom, V. J.; Mayes, D.; Wagoner, G.; Phillips, N.; Silver, J. Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J. Neurosci., 2006, 26(28), 7405-7415.
62. Tom, V. J.; Sandrow-Feinberg, H. R.; Miller, K.; Santi, L.; Connors, T.; Lemay, M. A.; Houlé, J. D. Combining peripheral nerve grafts and chondroitinase promotes functional axonal regeneration in the chronically injured spinal cord. J. Neurosci., 2009, 29(47), 14881-14890.
63. Rasouli, A.; Bhatia, N.; Suryadevara, S.; Cahill, K.; Gupta, R. Transplantation of preconditioned schwann cells in peripheral nerve grafts after contusion in the adult spinal cord. Improvement of recovery in a rat model. J. Bone Joint Surg. Am., 2006, 88(11), 2400-2410.
64. Lu, J.; Féron, F.; Ho, S. M.; Mackay-Sim, A.; Waite, P. M. Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats. Brain Res., 2001, 889 (1-2), 344-357.
65. Li, Y.; Decherchi, P.; Raisman, G. Transplantation of olfactory ensheathing cells into spinal cord lesions restores breathing and climbing. J. Neurosci., 2003, 23(3), 727-731.
66. Li, Y.; Field, P. M.; Raisman, G. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science (Wash.), 1997, 277(5334), 2000-2002.
67. Riddell, J. S.; Enriquez-Denton, M.; Toft, A.; Fairless, R.; Barnett, S. C. Olfactory ensheathing cell grafts have minimal influence on regeneration at the dorsal root entry zone following rhizotomy. Glia, 2004, 47(2), 150-167.
68. Féron, F.; Perry, C.; Cochrane, J.; Licina, P.; Nowitzke, A.; Urquhart, S.; Geraghty, T.; Mackay-Sim, A. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain: J. Neurol., 2005, 128 (Pt 12), 2951-2960.
69. Lima, C.; Pratas-Vital, J.; Escada, P.; Hasse-Ferreira, A.; Capucho, C.; Peduzzi, J. D. Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J. Spinal Cord Med., 2006, 29(3), 191-203; discussion 204-206.
70. Huang, H.; Chen, L.; Wang, H.; Xi, H.; Gou, C.; Zhang, J.; Zhang, F.; Liu, Y. Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury. A 38-month follow-up with MRI. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2006, 20(4), 439-443.
71. Dobkin, B. H.; Curt, A.; Guest, J. Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehab. Neural Repair, 2006, 20(1), 5-13.
72. Chiu, S.-C.; Hung, H.-S.; Lin, S.-Z.; Chiang, E.; Liu, D. D. Therapeutic potential of olfactory ensheathing cells in neurodegenerative diseases. J. Mol. Med., 2009, 87(12), 1179-1189.
73. Fouad, K.; Schnell, L.; Bunge, M. B.; Schwab, M. E.; Liebscher, T.; Pearse, D. D. Combining Schwann cell bridges and olfactoryensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J. Neurosci., 2005, 25(5), 1169-1178.
74. Solter, D. From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research. Nat. Rev. Genet., 2006, 7(4), 319-327.
75. Koch, C. A.; Geraldes, P.; Platt, J. L. Immunosuppression by embryonic stem cells. Stem Cells, 2008, 26(1), 89-98.
76. Matsunaga, Y.; Fukuma, D.; Hirata, S.; Fukushima, S.; Haruta, M.; Ikeda, T.; Negishi, I.; Nishimura, Y.; Senju, S. Activation of antigen-specific cytotoxic T lymphocytes by beta 2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cells. J. Immunol., 2008, 181(9), 6635-6643.
77. Beachy, P. A.; Karhadkar, S. S.; Berman, D. M. Tissue repair and stem cell renewal in carcinogenesis. Nature, 2004, 432(7015), 324-331.
78. Cajal, S. R.y.; DeFelipe, J.; Jones, E. G., Cajal's degeneration and regeneration of the nervous system. Oxford University Press US: 1991.
79. Altman, J. Are new neurons formed in the brains of adult mammals? Science (Wash.), 1962, 135, 1127-1128.
80. Leblond, C. P. Classification of cell populations on the basis of their proliferative behavior. Natl. Cancer Inst. Monogr., 1964, 14, 119-150.
81. Messier, B.; Leblond, C. P.; Smart, I. Presence of DNA synthesis and mitosis in the brain of young adult mice. Exp. Cell Res., 1958, 14(1), 224-226.
82. Eriksson, P. S.; Perfilieva, E.; Björk-Eriksson, T.; Alborn, A. M.; Nordborg, C.; Peterson, D. A.; Gage, F. H. Neurogenesis in the adult human hippocampus. Nat. Med., 1998, 4(11), 1313-1317.
83. Paterson, J. A.; Privat, A.; Ling, E. A.; Leblond, C. P. Investigation of glial cells in semithin sections. 3. Transformation of subependymal cells into glial cells, as shown by radioautography after 3 H-thymidine injection into the lateral ventricle of the brain of young rats. J. Comp. Neurol., 1973, 149(1), 83-102.
84. Rietze, R.; Poulin, P.; Weiss, S. Mitotically active cells that generate neurons and astrocytes are present in multiple regions of the adult mouse hippocampus. J. Comp. Neurol., 2000, 424(3), 397-408.
85. Weiss, S.; Dunne, C.; Hewson, J.; Wohl, C.; Wheatley, M.; Peterson, A. C.; Reynolds, B. A. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J. Neurosci. Off. J. Soc. Neurosci., 1996, 16(23), 7599-7609.
86. Dawson, M. R. L.; Polito, A.; Levine, J. M.; Reynolds, R. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol. Cell. Neurosci., 2003, 24(2), 476-488.
87. Meletis, K.; Barnabé-Heider, F.; Carlén, M.; Evergren, E.; Tomilin, N.; Shupliakov, O.; Frisén, J. Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol., 2008, 6(7), e182.
88. Amoh, Y.; Kanoh, M.; Niiyama, S.; Hamada, Y.; Kawahara, K.; Sato, Y.; Hoffman, R. M.; Katsuoka, K. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheralnerve injury: an advantageous alternative to ES and iPS cells. J. Cell. Biochem., 2009, 107(5), 1016-1020.
89. Lim, J. H.; Byeon, Y. E.; Ryu, H. H.; Jeong, Y. H.; Lee, Y. W.; Kim, W. H.; Kang, K. S.; Kweon, O. K. Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. J. Vet. Sci., 2007, 8(3), 275-282.
90. Dasari, V. R.; Spomar, D. G.; Li, L.; Gujrati, M.; Rao, J. S.; Dinh, D. H. Umbilical cord blood stem cell mediated downregulation of fas improves functional recovery of rats after spinal cord injury. Neurochem. Res., 2008, 33(1), 134-149.
91. Phinney, D. G.; Prockop, D. J. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells, 2007, 25(11), 2896-2902.
92. Hochedlinger, K.; Jaenisch, R. Nuclear reprogramming and pluripotency. Nature, 2006, 441(7097), 1061-1067.
93. Tao, H.; Ma, D. D. F. Evidence for transdifferentiation of human bone marrow-derived stem cells: recent progress and controversies. Pathology, 2003, 35(1), 6-13.
94. Yamanaka, S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell, 2007, 1(1), 39-49.
95. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4), 663-676.
96. Slack, J. M. W. Metaplasia and transdifferentiation: from pure biology to the clinic. Nat. Rev. Mol. Cell Biol., 2007, 8(5), 369-378.
97. Lee, H.; Park, J.; Forget, B. G.; Gaines, P. Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells. Regen. Med, 2009, 4(5), 759-769.
98. Salewski, R. P. F.; Eftekharpour, E.; Fehlings, M. G. Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury? J. Cell Physiol., 2010, 222(3), 515-521.
99. Yang, X.; Smith, S. L.; Tian, X. C.; Lewin, H. A.; Renard, J.-P.; Wakayama, T. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat. Genet., 2007, 39(3), 295-302.
100. French, A. J.; Adams, C. A.; Anderson, L. S.; Kitchen, J. R.; Hughes, M. R.; Wood, S. H. Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells, 2008, 26(2), 485-493.
101. Byrne, J. A.; Pedersen, D. A.; Clepper, L. L.; Nelson, M.; Sanger, W. G.; Gokhale, S.; Wolf, D. P.; Mitalipov, S. M. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature, 2007, 450(7169), 497-502.
102. Boido, M.; Rupa, R.; Garbossa, D.; Fontanella, M.; Ducati, A.; Vercelli, A. Embryonic and adult stem cells promote raphespinal axon outgrowth and improve functional outcome following spinal hemisection in mice. Eur. J. Neurosci., 2009, 30(5), 833-846.
103. Sharp, J.; Keirstead, H. S. Therapeutic applications of oligodendrocyte precursors derived from human embryonic stem cells. Curr. Opin. Biotechnol., 2007, 18(5), 434-440.
104. Liu, S.; Qu, Y.; Stewart, T. J.; Howard, M. J.; Chakrabortty, S.; Holekamp, T. F.; McDonald, J. W. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc. Natl. Acad. Sci. U. S. A., 2000, 97(11), 6126-6131.
105. Deshpande, D. M.; Kim, Y.-S.; Martinez, T.; Carmen, J.; Dike, S.; Shats, I.; Rubin, L. L.; Drummond, J.; Krishnan, C.; Hoke, A.; Maragakis, N.; Shefner, J.; Rothstein, J. D.; Kerr, D. A. Recovery from paralysis in adult rats using embryonic stem cells. Ann. Neurol., 2006, 60(1), 32-44.
106. Gates, M. A.; Thomas, L. B.; Howard, E. M.; Laywell, E. D.; Sajin, B.; Faissner, A.; Götz, B.; Silver, J.; Steindler, D. A. Cell and molecular analysis of the developing and adult mouse subventricular zone of the cerebral hemispheres. J. Comp. Neurol., 1995, 361(2), 249-266.
107. Suhonen, J. O.; Peterson, D. A.; Ray, J.; Gage, F. H. Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo. Nature, 1996, 383(6601), 624-627.
108. Herrera, D. G.; Garcia-Verdugo, J. M.; Alvarez-Buylla, A. Adultderived neural precursors transplanted into multiple regions in the adult brain. Ann. Neurol., 1999, 46(6), 867-877.
109. Shihabuddin, L. S.; Horner, P. J.; Ray, J.; Gage, F. H. Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus. J. Neurosci., 2000, 20(23), 8727-8735.
110. Lie, D. C.; Dziewczapolski, G.; Willhoite, A. R.; Kaspar, B. K.; Shults, C. W.; Gage, F. H. The adult substantia nigra contains progenitor cells with neurogenic potential. J. Neurosci., 2002, 22(15), 6639-6649.
111. Doetsch, F. A niche for adult neural stem cells. Curr. Opin. Genet. Dev., 2003, 13(5), 543-550.
112. Horner, P. J.; Power, A. E.; Kempermann, G.; Kuhn, H. G.; Palmer, T. D.; Winkler, J.; Thal, L. J.; Gage, F. H. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J. Neurosci., 2000, 20(6), 2218-2228.
113. Foret, A.; Quertainmont, R.; Botman, O.; Bouhy, D.; Amabili, P.; Brook, G.; Schoenen, J.; Franzen, R. Stem cells in the adult rat spinal cord: plasticity after injury and treadmill training exercise. J. Neurochem., 2010, 112(3), 762-772.
114. Kehl, L. J.; Fairbanks, C. A.; Laughlin, T. M.; Wilcox, G. L. Neurogenesis in postnatal rat spinal cord: a study in primary culture. Science (Wash.), 1997, 276(5312), 586-589.
115. Tzeng, S.-F. Neural progenitors isolated from newborn rat spinal cords differentiate into neurons and astroglia. J. Biomed. Sci., 2002, 9(1), 10-16.
116. Cao, Q. L.; Zhang, Y. P.; Howard, R. M.; Walters, W. M.; Tsoulfas, P.; Whittemore, S. R. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp. Neurol., 2001, 167(1), 48-58.
117. Yamamoto, S.; Yamamoto, N.; Kitamura, T.; Nakamura, K.; Nakafuku, M. Proliferation of parenchymal neural progenitors in response to injury in the adult rat spinal cord. Exp. Neurol., 2001, 172(1), 115-127.
118. Park, H.-W.; Lim, M.-J.; Jung, H.; Lee, S.-P.; Paik, K.-S.; Chang, M.-S. Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury. Glia, 2010, 58(9), 1118-1132.
119. Sigurjonsson, O. E.; Perreault, M.-C.; Egeland, T.; Glover, J. C. Adult human hematopoietic stem cells produce neurons efficiently in the regenerating chicken embryo spinal cord. Proc. Natl. Acad. Sci. U. S. A., 2005, 102(14), 5227-5232.
120. Cao, Q.; Ding, P.; Lu, J.; Dheen, S. T.; Moochhala, S.; Ling, E.-A. 2', 3'-Cyclic nucleotide 3'-phosphodiesterase cells derived from transplanted marrow stromal cells and host tissue contribute to perineurial compartment formation in injured rat spinal cord. J. Neurosci. Res., 2007, 85(1), 116-130.
121. Kamei, N.; Kwon, S.-M.; Alev, C.; Ishikawa, M.; Yokoyama, A.; Nakanishi, K.; Yamada, K.; Horii, M.; Nishimura, H.; Takaki, S.; Kawamoto, A.; Ii, M.; Akimaru, H.; Tanaka, N.; Nishikawa, S.-I.; Ochi, M.; Asahara, T. Lnk deletion reinforces the function of bone marrow progenitors in promoting neovascularization and astrogliosis following spinal cord injury. Stem Cells, 2010, 28(2), 365-375.
122. Sasaki, H.; Ishikawa, M.; Tanaka, N.; Nakanishi, K.; Kamei, N.; Asahara, T.; Ochi, M. Administration of human peripheral bloodderived CD133+ cells accelerates functional recovery in a rat spinal cord injury model. Spine, 2009, 34(3), 249-254.
123. Rauch, M. F.; Hynes, S. R.; Bertram, J.; Redmond, A.; Robinson, R.; Williams, C.; Xu, H.; Madri, J. A.; Lavik, E. B. Engineering angiogenesis following spinal cord injury: a coculture of neural progenitor and endothelial cells in a degradable polymer implant leads to an increase in vessel density and formation of the bloodspinal cord barrier. Eur. J. Neurosci., 2009, 29(1), 132-145.
124. Numano, F.; Inoue, A.; Enomoto, M.; Shinomiya, K.; Okawa, A.; Okabe, S. Critical involvement of Rho GTPase activity in the efficient transplantation of neural stem cells into the injured spinal cord. Mol. Brain, 2009, 2(1), 37.
125. Johnson, P. J.; Tatara, A.; Shiu, A.; Sakiyama-Elbert, S. E. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant., 2010, 19(1), 89-101.
126. Lu, P.; Jones, L. L.; Snyder, E. Y.; Tuszynski, M. H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol., 2003, 181(2), 115-129.
127. Parr, A. M.; Tator, C. H.; Keating, A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant., 2007, 40(7), 609-619.
128. García, R.; Aguiar, J.; Alberti, E.; de la Cuétara, K.; Pavón, N. Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors. Biochem. Biophys. Res. Commun., 2004, 316(3), 753-754.
129. Reynolds, B. A.; Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science (Wash.), 1992, 255(5052), 1707-1710.
130. Gago, N.; Avellana-Adalid, V.; Evercooren, A. B.-V.; Schumacher, M. Control of cell survival and proliferation of postnatal PSA-NCAM (+) progenitors. Mol. Cell Neurosci., 2003, 22(2), 162-178.
131. Aberg, M. A.; Aberg, N. D.; Hedbäcker, H.; Oscarsson, J.; Eriksson, P. S. Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J. Neurosci., 2000, 20(8), 2896-2903.
132. Arsenijevic, Y.; Weiss, S.; Schneider, B.; Aebischer, P. Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2. J. Neurosci., 2001, 21(18), 7194-7202.
133. Hsieh, J.; Aimone, J. B.; Kaspar, B. K.; Kuwabara, T.; Nakashima, K.; Gage, F. H. IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes. J. Cell Biol., 2004, 164(1), 111-122.
134. Barnabé-Heider, F.; Miller, F. D. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J. Neurosci., 2003, 23(12), 5149-5160.
135. Ohta, M.; Suzuki, Y.; Noda, T.; Ejiri, Y.; Dezawa, M.; Kataoka, K.; Chou, H.; Ishikawa, N.; Matsumoto, N.; Iwashita, Y.; Mizuta, E.; Kuno, S.; Ide, C. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp. Neurol., 2004, 187(2), 266-278.
136. Lladó, J.; Haenggeli, C.; Maragakis, N. J.; Snyder, E. Y.; Rothstein, J. D. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol. Cell. Neurosci., 2004, 27(3), 322-331.
137. Veeravalli, K. K.; Dasari, V. R.; Tsung, A. J.; Dinh, D. H.; Gujrati, M.; Fassett, D.; Rao, J. S. Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury. Neurobiol. Dis., 2009, 36(1), 200-212.
138. Kim, H. M.; Hwang, D. H.; Lee, J. E.; Kim, S. U.; Kim, B. G. Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PloS One, 2009, 4(3), e4987.
139. Yang, H.; Lu, P.; McKay, H. M.; Bernot, T.; Keirstead, H.; Steward, O.; Gage, F. H.; Edgerton, V. R.; Tuszynski, M. H. Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury. J. Neurosci., 2006, 26(8), 2157-2166.
140. Martens, D. J.; Seaberg, R. M.; van der Kooy, D. In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord. Eur. J. Neurosci., 2002, 16(6), 1045-1057.
141. Zai, L. J.; Wrathall, J. R. Cell proliferation and replacement following contusive spinal cord injury. Glia, 2005, 50(3), 247-257.
142. Ohori, Y.; Yamamoto, S.-i.; Nagao, M.; Sugimori, M.; Yamamoto, N.; Nakamura, K.; Nakafuku, M. Growth factor treatment and genetic manipulation stimulate neurogenesis and oligodendrogenesis by endogenous neural progenitors in the injured adult spinal cord. J. Neurosci., 2006, 26(46), 11948-11960.
143. Hardy, S. A.; Maltman, D. J.; Przyborski, S. A. Mesenchymal stem cells as mediators of neural differentiation. Curr. Stem Cell Res. Ther., 2008, 3(1), 43-52.
144. Mikami, Y.; Okano, H.; Sakaguchi, M.; Nakamura, M.; Shimazaki, T.; Okano, H. J.; Kawakami, Y.; Toyama, Y.; Toda, M. Implantation of dendritic cells in injured adult spinal cord results in activation of endogenous neural stem/progenitor cells leading to de novo neurogenesis and functional recovery. J. Neurosci. Res., 2004, 76(4), 453-465.
145. Pfeifer, K.; Vroemen, M.; Blesch, A.; Weidner, N. Adult neural progenitor cells provide a permissive guiding substrate for corticospinal axon growth following spinal cord injury. Eur. J. Neurosci., 2004, 20(7), 1695-1704.
146. Hofstetter, C. P.; Schwarz, E. J.; Hess, D.; Widenfalk, J.; El Manira, A.; Prockop, D. J.; Olson, L. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. U. S. A., 2002, 99(4), 2199-2204.
147. Zhang, X.; Zeng, Y.; Zhang, W.; Wang, J.; Wu, J.; Li, J. Cotransplantation of neural stem cells and NT-3-overexpressing Schwann cells in
148. Tuszynski, M. H.; Murai, K.; Blesch, A.; Grill, R.; Miller, I. Functional characterization of NGF-secreting cell grafts to the acutely injured spinal cord. Cell Transplant., 1997, 6(3), 361-368.
149. Bukovsky, A.; Caudle, M. R.; Svetlikova, M. Steroid-mediated differentiation of neural/neuronal cells from epithelial ovarian precursors in vitro. Cell Cycle, 2008, 7(22), 3577-3583.
150. Fouad, K.; Klusman, I.; Schwab, M. E. Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1. Eur. J. Neurosci., 2004, 20(9), 2479-2482.
151. Cao, Q.; Zhang, Y. P.; Iannotti, C.; DeVries, W. H.; Xu, X.-M.; Shields, C. B.; Whittemore, S. R. Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat. Exp. Neurol., 2005, 191 (Suppl 1), S3-S16.
152. Koda, M.; Nishio, Y.; Hashimoto, M.; Kamada, T.; Koshizuka, S.; Yoshinaga, K.; Onodera, S.; Nishihira, J.; Moriya, H.; Yamazaki, M. Up-regulation of macrophage migration-inhibitory factor expression after compression-induced spinal cord injury in rats. Acta Neuropathol. (Berl). 2004, 108(1), 31-36.
153. Poon, P. C.; Gupta, D.; Shoichet, M. S.; Tator, C. H. Clip compression model is useful for thoracic spinal cord injuries: histologic and functional correlates. Spine, 2007, 32(25), 2853-2859.
154. Kouyoumdjian, P.; Lonjon, N.; Prieto, M.; Haton, H.; Privat, A.; Asencio, G.; Perrin, F. E.; Gaviria, M. A remotely controlled model of spinal cord compression injury in mice: toward real-time analysis. J. Neurosurg., 2009, 11(4), 461-470.
155. Courtine, G.; Bunge, M. B.; Fawcett, J. W.; Grossman, R. G.; Kaas, J. H.; Lemon, R.; Maier, I.; Martin, J.; Nudo, R. J.; Ramon-Cueto, A.; Rouiller, E. M.; Schnell, L.; Wannier, T.; Schwab, M. E.; Edgerton, V. R. Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans? Nat. Med., 2007, 13(5), 561-566.
156. Iwanami, A.; Kaneko, S.; Nakamura, M.; Kanemura, Y.; Mori, H.; Kobayashi, S.; Yamasaki, M.; Momoshima, S.; Ishii, H.; Ando, K.; Tanioka, Y.; Tamaoki, N.; Nomura, T.; Toyama, Y.; Okano, H. Transplantation of human neural stem cells for spinal cord injury in primates. J. Neurosci. Res., 2005, 80(2), 182-190.
157. McDonald, J. W.; Liu, X. Z.; Qu, Y.; Liu, S.; Mickey, S. K.; Turetsky, D.; Gottlieb, D. I.; Choi, D. W. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med., 1999, 5(12), 1410-1412.
158. Ogawa, Y.; Sawamoto, K.; Miyata, T.; Miyao, S.; Watanabe, M.; Nakamura, M.; Bregman, B. S.; Koike, M.; Uchiyama, Y.; Toyama, Y.; Okano, H. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J. Neurosci. Res., 2002, 69(6), 925-933.
159. Cummings, B. J.; Uchida, N.; Tamaki, S. J.; Salazar, D. L.; Hooshmand, M.; Summers, R.; Gage, F. H.; Anderson, A. J. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. U. S. A., 2005, 102(39), 14069-14074.
160. Koshizuka, S.; Okada, S.; Okawa, A.; Koda, M.; Murasawa, M.; Hashimoto, M.; Kamada, T.; Yoshinaga, K.; Murakami, M.; Moriya, H.; Yamazaki, M. Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice. J. Neuropathol. Exp. Neurol., 2004, 63(1), 64-72.
161. Koda, M.; Okada, S.; Nakayama, T.; Koshizuka, S.; Kamada, T.; Nishio, Y.; Someya, Y.; Yoshinaga, K.; Okawa, A.; Moriya, H.; Yamazaki, M. Hematopoietic stem cell and marrow stromal cell for spinal cord injury in mice. Neuroreport, 2005, 16(16), 1763-1767.
162. Yang, C.-C.; Shih, Y.-H.; Ko, M.-H.; Hsu, S.-Y.; Cheng, H.; Fu, Y.-S. Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PloS One, 2008, 3(10), e3336.
163. Kerr, C. L.; Letzen, B. S.; Hill, C. M.; Agrawal, G.; Thakor, N. V.; Sterneckert, J. L.; Gearhart, J. D.; All, A. H. Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury. Int. J. Neurosci., 2010, 120(4), 305-313.
164. Tsuji, O.; Miura, K.; Okada, Y.; Fujiyoshi, K.; Mukaino, M.; Nagoshi, N.; Kitamura, K.; Kumagai, G.; Nishino, M.; Tomisato, S.; Higashi, H.; Nagai, T.; Katoh, H.; Kohda, K.; Matsuzaki, Y.; Yuzaki, M.; Ikeda, E.; Toyama, Y.; Nakamura, M.; Yamanaka, S.; Okano, H. Therapeutic potential of appropriately evaluated safeinduced pluripotent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. U. S. A., 2010, 107(28), 12704-12709.
165. Cizkova, D.; Cizek, M.; Nagyova, M.; Slovinska, L.; Novotna, I.; Jergova, S.; Radonak, J.; Hlucilova, J.; Vanicky, I. Enrichment of rat oligodendrocyte progenitor cells by magnetic cell sorting. J. Neurosci. Methods, 2009, 184(1), 88-94.
166. Okada, S.; Ishii, K.; Yamane, J.; Iwanami, A.; Ikegami, T.; Katoh, H.; Iwamoto, Y.; Nakamura, M.; Miyoshi, H.; Okano, H. J.; Contag, C. H.; Toyama, Y.; Okano, H. In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J., 2005, 19(13), 1839-1841.
167. Kigerl, K. A.; Popovich, P. G. Toll-like receptors in spinal cord injury. Curr. Top. Microbiol. Immunol., 2009, 336, 121-136.
168. Okada, S.; Nakamura, M.; Mikami, Y.; Shimazaki, T.; Mihara, M.; Ohsugi, Y.; Iwamoto, Y.; Yoshizaki, K.; Kishimoto, T.; Toyama, Y.; Okano, H. Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J. Neurosci. Res., 2004, 76(2), 265-276.
169. Björklund, A.; Lindvall, O. Self-repair in the brain. Nature, 2000, 405(6789), 892-893, 895.
170. Snyder, E. Y.; Park, K. I. Limitations in brain repair. Nat. Med., 2002, 8(9), 928-930.
171. Goldman, S. Stem and progenitor cell-based therapy of the human central nervous system. Nat. Biotechnol., 2005, 23(7), 862-871.
172. Lee, S. I.; Kim, B. G.; Hwang, D. H.; Kim, H. M.; Kim, S. U. Overexpression of Bcl-XL in human neural stem cells promotes graft survival and functional recovery following transplantation in spinal cord injury. J. Neurosci. Res., 2009, 87(14), 3186-3197.
173. Hu, S.-L.; Zhang, J.-Q.; Hu, X.; Hu, R.; Luo, H.-S.; Li, F.; Xia, Y.-Z.; Li, J.-T.; Lin, J.-K.; Zhu, G.; Feng, H. In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles. J. Cell. Biochem., 2009, 108(2), 529-535.
174. Shen, J.; Zhong, X.-M.; Duan, X.-H.; Cheng, L.-N.; Hong, G.-b.; Bi, X.-B.; Liu, Y. Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury. Acad. Radiol., 2009, 16(9), 1142-1154.
175. Hawryluk, G. W. J.; Rowland, J.; Kwon, B. K.; Fehlings, M. G. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg. Focus, 2008, 25(5), E14.
176. Reier, P. J. Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx J. Am. Soc. Exper. NeuroTherap., 2004, 1(4), 424-451.
177. Steeves, J.; Fawcett, J.; Tuszynski, M. Report of international clinical trials workshop on spinal cord injury February 20-21, Vancouver, Canada. Spinal Cord, 2004, 42(10), 591-597.
178. Yoon, S. H.; Shim, Y. S.; Park, Y. H.; Chung, J. K.; Nam, J. H.; Kim, M. O.; Park, H. C.; Park, S. R.; Min, B.-H.; Kim, E. Y.; Choi, B. H.; Park, H.; Ha, Y. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells, 2007, 25(8), 2066-2073.
179. Abdelaziz, O. S.; Marie, A.; Abbas, M.; Ibrahim, M.; Gabr, H. Feasibility, safety, and efficacy of directly transplanting autologous adult bone marrow stem cells in patients with chronic traumatic dorsal cord injury. Neurosurgery Quarterly, 2010, 20(3), 216-226.
180. Baptiste, D. C.; Fehlings, M. G. Update on the treatment of spinal cord injury. Prog. Brain Res., 2007, 161, 217-233.
181. Deda, H.; Inci, M. C.; Kürekçi, A. E.; Kayihan, K.; Ozgün, E.; Ustünsoy, G. E.; Kocabay, S. Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy, 2008, 10(6), 565-574.
182. Alper, J. Geron gets green light for human trial of ES cell-derived product. Nat. Biotechnol., 2009, 27(3), 213-214.
183. Qiu, J. China Spinal Cord Injury Network: changes from within. Lancet Neurol, 2009, 8(7), 606-607.
184. Keirstead, H. S.; Nistor, G.; Bernal, G.; Totoiu, M.; Cloutier, F.; Sharp, K.; Steward, O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci., 2005, 25(19), 4694-4705.
185. Lacitignola, L.; Crovace, A.; Rossi, G.; Francioso, E. Cell therapy for tendinitis, experimental and clinical report. Vet. Res. Commun., 2008, 32 Suppl 1, S33-38.
186. Fawcett, J. W.; Curt, A.; Steeves, J. D.; Coleman, W. P.; Tuszynski, M. H.; Lammertse, D.; Bartlett, P. F.; Blight, A. R.; Dietz, V.; Ditunno, J.; Dobkin, B. H.; Havton, L. A.; Ellaway, P. H.; Fehlings, M. G.; Privat, A.; Grossman, R.; Guest, J. D.; Kleitman, N.; Nakamura, M.; Gaviria, M.; Short, D. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord, 2007, 45(3), 190-205.
187. Marino, R. J.; Barros, T.; Biering-Sorensen, F.; Burns, S. P.; Donovan, W. H.; Graves, D. E.; Haak, M.; Hudson, L. M.; Priebe, M. M. International standards for neurological classification of spinal cord injury. J. Spinal Cord Med., 2003, 26 (Suppl 1), S50-56.
188. Kirshblum, S. C.; Memmo, P.; Kim, N.; Campagnolo, D.; Millis, S. Comparison of the revised 2000 American Spinal Injury Association classification standards with the 1996 guidelines. Am. J. Phys. Med. Rehabil., 2002, 81(7), 502-505.
189. Coleman, W. P.; Geisler, F. H. Injury severity as primary predictor of outcome in acute spinal cord injury: retrospective results from a large multicenter clinical trial. Spine J, 2004, 4(4), 373-378.
190. Linassi, G.; Li Pi Shan, R.; Marino, R. J. A web-based computer program to determine the ASIA impairment classification. Spinal Cord, 2010, 48(2), 100-104.
191. van Middendorp, J. J.; Hosman, A. J. F.; Pouw, M. H.; Van de Meent, H. Is determination between complete and incomplete traumatic spinal cord injury clinically relevant? Validation of the ASIA sacral sparing criteria in a prospective cohort of 432 patients. Spinal Cord, 2009, 47(11), 809-816.
192. Anderson, D. K.; Beattie, M.; Blesch, A.; Bresnahan, J.; Bunge, M.; Dietrich, D.; Dietz, V.; Dobkin, B.; Fawcett, J.; Fehlings, M.; Fischer, I.; Grossman, R.; Guest, J.; Hagg, T.; Hall, E. D.; Houle, J.; Kleitman, N.; McDonald, J.; Murray, M.; Privat, A.; Reier, P.; Steeves, J.; Steward, O.; Tetzlaff, W.; Tuszynski, M. H.; Waxman, S. G.; Whittemore, S.; Wolpaw, J.; Young, W.; Zheng, B. Recommended guidelines for studies of human subjects with spinal cord injury. Spinal Cord, 2005, 43(8), 453-458.
193. Ellingson, B. M.; Ulmer, J. L.; Schmit, B. D. Morphology and morphometry of human chronic spinal cord injury using diffusion tensor imaging and fuzzy logic. Ann. Biomed. Eng., 2008, 36(2), 224-236.
194. Patel, C. B. Consider using diffusion tensor imaging in Geron phase I trial. Am. J. Neuroradiol., 2009, 30(7), E97.
195. Sagen, J. Cellular therapies for spinal cord injury: what will the FDA need to approve moving from the laboratory to the human? J. Rehabil. Res. Dev., 2003, 40 (4 Suppl 1), 71-79.
196. Paul, C.; Samdani, A. F.; Betz, R. R.; Fischer, I.; Neuhuber, B. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Spine, 2009, 34(4), 328-334.
197. Saito, F.; Nakatani, T.; Iwase, M.; Maeda, Y.; Hirakawa, A.; Murao, Y.; Suzuki, Y.; Onodera, R.; Fukushima, M.; Ide, C. Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J. Trauma, 2008, 64(1), 53-59.
198. Geffner, L. F.; Santacruz, P.; Izurieta, M.; Flor, L.; Maldonado, B.; Auad, A. H.; Montenegro, X.; Gonzalez, R.; Silva, F. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant., 2008, 17(12), 1277-1293.
199. Ko, J.-Y.; Lee, H.-S.; Park, C.-H.; Koh, H.-C.; Lee, Y.-S.; Lee, S.-H. Conditions for tumor-free and dopamine neuron-enriched grafts after transplanting human ES cell-derived neural precursor cells. Mol. Ther., 2009, 17(10), 1761-1770.
200. Noel, A.; Simon, N.; Raus, J.; Foidart, J. M. Basement membrane components (matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen. Biochem. Pharmacol., 1992, 43(6), 1263-1267.
201. Ueno, M.; Matsumura, M.; Watanabe, K.; Nakamura, T.; Osakada, F.; Takahashi, M.; Kawasaki, H.; Kinoshita, S.; Sasai, Y. Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix. Proc. Natl. Acad. Sci. U. S. A., 2006, 103(25), 9554-9559.
202. Nistor, G. I.; Totoiu, M. O.; Haque, N.; Carpenter, M. K.; Keirstead, H. S. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia, 2005, 49(3), 385-396.
203. Hwang, D. H.; Kim, B. G.; Kim, E. J.; Lee, S. I.; Joo, I. S.; Suh-Kim, H.; Sohn, S.; Kim, S. U. Transplantation of human neural stem cells transduced with Olig2 transcription factor improves locomotor recovery and enhances myelination in the white matter of rat spinal cord following contusive injury. BMC Neurosci., 2009, 10, 117.
204. Zhang, Y.-Q.; Zeng, X.; He, L.-M.; Ding, Y.; Li, Y.; Zeng, Y.-S. NT-3 gene modified Schwann cells promote TrkC gene modified mesenchymal stem cells to differentiate into neuron-like cells in vitro. Anat Sci Int, 2010, 85(2), 61-67.
205. Maeda, K.; Kanno, H.; Yamazaki, Y.; Kubo, A.; Sato, F.; Yamaguchi, Y.; Saito, T. Transplantation of Vo n Hippel-Lindau peptide delivered neural stem cells promotes recovery in the injured rat spinal cord. Neuroreport, 2009, 20(17), 1559-1563.
206. Wakao, S.; Hayashi, T.; Kitada, M.; Kohama, M.; Matsue, D.; Teramoto, N.; Ose, T.; Itokazu, Y.; Koshino, K.; Watabe, H.; Iida, H.; Takamoto, T.; Tabata, Y.; Dezawa, M. Long-term observation of auto-cell transplantation in non-human primate reveals safety and efficiency of bone marrow stromal cell-derived Schwann cells in peripheral nerve regeneration. Exp. Neurol., 2010, 223(2), 537-547.
207. Matsuda, R.; Yoshikawa, M.; Kimura, H.; Ouji, Y.; Nakase, H.; Nishimura, F.; Nonaka, J.-i.; Toriumi, H.; Yamada, S.; Nishiofuku, M.; Moriya, K.; Ishizaka, S.; Nakamura, M.; Sakaki, T. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development. Cell Transplant., 2009, 18(1), 39-54
208. Nakagawa, M.; Takizawa, N.; Narita, M.; Ichisaka, T.; Yamanaka, S. Promotion of direct reprogramming by transformation-deficient Myc. Proc. Natl. Acad. Sci. U. S. A., 2010, 107(32), 14152-14157.
209. Kim, J. B.; Greber, B.; Araúzo-Bravo, M. J.; Meyer, J.; Park, K. I.; Zaehres, H.; Schöler, H. R. Direct reprogramming of human neural stem cells by OCT4. Nature, 2009, 461(7264), 649-643.
210. Miura, K.; Okada, Y.; Aoi, T.; Okada, A.; Takahashi, K.; Okita, K.; Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Ohnuki, M.; Ogawa, D.; Ikeda, E.; Okano, H.; Yamanaka, S. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol., 2009, 27(8), 743-745.
211. Kim, K.; Doi, A.; Wen, B.; Ng, K.; Zhao, R.; Cahan, P.; Kim, J.; Aryee, M. J.; Ji, H.; Ehrlich, L. I. R.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; McKinney-Freeman, S.; Naveiras, O.; Yoon, T. J.; Irizarry, R. A.; Jung, N.; Seita, J.; Hanna, J.; Murakami, P.; Jaenisch, R.; Weissleder, R.; Orkin, S. H.; Weissman, I. L.; Feinberg, A. P.; Daley, G. Q. Epigenetic memory in induced pluripotent stem cells. Nature, 2010, doi:10.1038/nature09342.
212. Macias, M. Y.; Syring, M. B.; Pizzi, M. A.; Crowe, M. J.; Alexanian, A. R.; Kurpad, S. N. Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. Exp. Neurol., 2006, 201(2), 335-348.
213. Hofstetter, C. P.; Holmström, N. A. V.; Lilja, J. A.; Schweinhardt, P.; Hao, J.; Spenger, C.; Wiesenfeld-Hallin, Z.; Kurpad, S. N.; Frisén, J.; Olson, L. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat. Neurosci., 2005, 8(3), 346-353.
214. U. S. Government. Code of Federal Regulations, 2006, 8(21), 720-746.
215. Halme, D. G.; Kessler, D. A. FDA regulation of stem-cell-based therapies. New Engl. J. Med., 2006, 355(16), 1730-1735.
216. Owens, J. Stem-cell treatments for spinal-cord injury may be worth the risk. Nature, 2009, 458(7242), 1101.
217. Mathews, D. J. H.; Sugarman, J.; Bok, H.; Blass, D. M.; Coyle, J. T.; Duggan, P.; Finkel, J.; Greely, H. T.; Hillis, A.; Hoke, A.; Johnson, R.; Johnston, M.; Kahn, J.; Kerr, D.; Kurtzberg, J.; Liao, S. M.; McDonald, J. W.; McKhann, G.; Nelson, K. B.; Rao, M.; Regenberg, A.; Siegel, A. W.; Smith, K.; Solter, D.; Song, H.; Vescovi, A.; Young, W.; Gearhart, J. D.; Faden, R. Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology, 2008, 71(4), 288-293.
218. Salehi, M.; Pasbakhsh, P.; Soleimani, M.; Abbasi, M.; Hasanzadeh, G.; Modaresi, M. H.; Sobhani, A. Repair of spinal cord injury by co-transplantation of embryonic stem cell-derived motor neuron and olfactory ensheathing cell. Iran Biomed. J., 2009, 13(3), 125-135.
219. Ao, Q.; Wang, A. J.; Chen, G. Q.; Wang, S. J.; Zuo, H. C.; Zhang, X. F. Combined transplantation of neural stem cells and olfactory ensheathing cells for the repair of spinal cord injuries. Med. Hypotheses, 2007, 69(6), 1234-1237.
220. Moviglia, G. A.; Varela, G.; Brizuela, J. A.; Moviglia Brandolino, M. T.; Farina, P.; Etchegaray, G.; Piccone, S.; Hirsch, J.; Martinez, G.; Marino, S.; Deffain, S.; Coria, N.; Gonzáles, A.; Sztanko, M.; Salas-Zamora, P.; Previgliano, I.; Aingel, V.; Farias, J.; Gaeta, C. A.; Saslavsky, J.; Blasseti, N. Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients. Spinal Cord, 2009, 47(6), 499-503.
221. Schröter, A.; Lustenberger, R. M.; Obermair, F. J.; Thallmair, M. High-dose corticosteroids after spinal cord injury reduce neural progenitor cell proliferation. Neuroscience, 2009, 161(3), 753-763.
222. Meng, X.-t; Li, C; Dong, Z.-y.; Liu, J.-m.; Li, W.; Liu, Y.; Xue, H.; Chen, D. Co-transplantation of bFGF-expressing amniotic epithelial cells and neural stem cells promotes functional recovery in spinal cord-injured rats. Cell Biol. Int., 2008, 32(12), 1546-1558.
223. Luo, J.; Zhang, H.-t; Jiang, X.-d.; Xue, S.; Ke, Y.-q. Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection. Acta Neurochir (Wien). 2009, 151(11), 1483-1492.
224. Sato, Y; Oohira, A. Chondroitin sulfate, a major niche substance of neural stem cells, and cell transplantation therapy of neurodegeneration combined with niche modification. Curr. Stem Cell Res. Ther., 2009, 4(3), 200-209.
225. Hejcl, A.; Lesny, P.; Prádny, M.; Michálek, J.; Jendelová, P.; Stulík, J.; Syková, E. Biocompatible hydrogels in spinal cord injury repair. Physiol. Res., 2008, 57 Suppl 3, S121-132.
226. Park, J.; Lim, E.; Back, S.; Na, H.; Park, Y; Sun, K. Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor. J. Biomed. Mater. Res., 2010, 93(3), 1091-1099.
227. Hatami, M.; Mehrjardi, N. Z.; Kiani, S.; Hemmesi, K.; Azizi, H.; Shahverdi, A.; Baharvand, H. Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord. Cytotherapy, 2009, 11(5), 618-630.
228. Bible, E.; Chau, D. Y. S.; Alexander, M. R.; Price, J.; Shakesheff, K. M.; Modo, M. Attachment of stem cells to scaffold particles for intra-cerebral transplantation. Nat. Prot., 2009, 4(10), 1440-1453.